Janssen to Showcase Growing Portfolio with More Than 40 Data Presentations at the 2015 American ...

(Source: Johnson & Johnson) Note: This release corresponds to ASH abstracts 29, 55, 57, 267, 377, 431, 469, 470, 495, 507, 508, 626, 699, 747, 833, 875, 894 RARITAN, NJ, November 5, 2015 - At the 57thAmerican Society of Hematology (ASH) Annual Meeting, Janssen Research & Development, LLC will present new data for both approved and investigational oncology and cardiovascular compounds across 10 disease areas. More than 40 abstracts from company-sponsored studies have been accepted for presentation, including 17 oral presentations, the largest presence of company data to date. Oral presentations from five Janssen brands across two therapeutic areas will be presented at the meeting, including...